Stocks · Healthcare · Medical - Diagnostics & Research
Sotera Health Company SHC
$18.22 +0.55% Close, Oct 2, 2026 · NASDAQ · Market cap $5.20B
Inexpensive vs sector
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $0.57, up 580.6% year over year.
- The shares trade at 31.8× trailing earnings, lower than 94% of the company's own readings over the past five years.
- Operating margin widened to 36.2% from 27.8% a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 48%
- EPS growth (TTM, YoY)Top 4%
- FCF growth (TTM, YoY)Bottom 41%
- Revenue growth, 3-year CAGRBottom 37%
- Revenue growth accelerationTop 38%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 17%
- Gross marginBottom 40%
- Operating marginTop 5%
- Cash conversion (OCF / net income)Top 39%
- Accruals (lower is better)Bottom 33%
- Net debt / EBITDA (lower is better)Bottom 24%
- Interest coverTop 33%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 17%
- Free-cash-flow yieldTop 29%
- EBITDA / enterprise valueTop 14%
- Sales / enterprise valueBottom 44%
- P/E vs own 5-year history (lower is better)Top 19%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 47%
- 6-month returnTop 38%
- 1-year return vs S&P 500Top 50%
- Distance from 52-week highTop 12%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 38%
- Consecutive EPS beatsTop 12%
- Share of analysts rating BuyTop 24%
- Upside to consensus price targetBottom 21%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 4%
- Maximum drawdown, 3 yearsTop 17%
- Beta vs S&P 500 (lower is better)Bottom 41%
- Net debt / EBITDA (lower is better)Bottom 24%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 7.4% | 8.1% | ↑ |
| EPS growth (YoY) | 372.2% | 580.6% | ↑ |
| Gross margin | 55.5% | 54.7% | ↓ |
| Operating margin | 27.8% | 36.2% | ↑ |
| FCF margin | 9.9% | 9.3% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 8.1% | 7.4% | ↑ | Bottom 48% |
| EPS growth (TTM, YoY) | 580.6% | 372.2% | ↑ | Top 4% |
| Gross margin | 54.7% | 55.5% | ↓ | Bottom 40% |
| Operating margin | 36.2% | 27.8% | ↑ | Top 5% |
| Net margin | 13.4% | 2.1% | ↑ | — |
| Free-cash-flow margin | 9.3% | 9.9% | ↓ | — |
| Return on invested capital | 8.8% | — | Top 17% | |
| Revenue growth, 3-year CAGR | 5.1% | — | Bottom 37% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.79×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -3.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 3.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +1.8 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 3.54×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 3.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.00%
- Shareholder yield
- 0.00%
- Share count change, 1 year
- +0.8%
- Share count change, 3-year CAGR
- +0.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 6
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +10.3%
- Average 2-day reaction, last 8
- +2.1%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $20.50
- Target vs current price
- +12.5%
- Analysts with a rating
- 12
- Share rating Buy or Strong Buy
- 92%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +8.8% | +5.2% | +5.1% | +5.5% | — |
| May 5, 2026 | +5.9% | -0.4% | +0.3% | -2.4% | +16.0% |
| Feb 24, 2026 | +8.3% | -4.4% | -9.0% | -20.6% | -12.9% |
| Nov 4, 2025 | +18.2% | -1.1% | -5.2% | +1.9% | +9.1% |
| Aug 8, 2025 | +17.6% | +24.5% | +40.5% | +39.2% | +48.0% |
| May 1, 2025 | +16.7% | +5.2% | +14.3% | +7.7% | +6.9% |
| Feb 27, 2025 | +0.0% | -10.0% | -13.3% | -14.3% | -10.1% |
| Nov 5, 2024 | -10.5% | -2.4% | +0.8% | -18.8% | -13.2% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | $0.26 | $0.24 | +8.8% | $321.4M |
| May 5, 2026 | $0.18 | $0.17 | +5.9% | $280.0M |
| Feb 24, 2026 | $0.26 | $0.24 | +8.3% | $303.4M |
| Nov 4, 2025 | $0.26 | $0.22 | +18.2% | $311.3M |
| Aug 8, 2025 | $0.20 | $0.17 | +17.6% | $294.3M |
| May 1, 2025 | $0.14 | $0.12 | +16.7% | $254.5M |
| Feb 27, 2025 | $0.21 | $0.21 | +0.0% | $290.2M |
| Nov 5, 2024 | $0.17 | $0.19 | -10.5% | $285.5M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 31.8× | 61.7× | 6th | Top 17% |
| P/E (forward) | 18.5× | — | — | — |
| EV / EBITDA | 13.2× | — | — | Top 14% |
| EV / Sales | 5.84× | — | — | Bottom 44% |
| Free-cash-flow yield | 2.17% | — | — | Top 29% |
| Earnings yield | 3.14% | — | — | Top 17% |
P/E over the past five years
Range 14.3× – 201.0× since Sep 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +12.5%
- Earnings per share growth (TTM)
- +580.6%
- Change in P/E multiple
- -80.1%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 71
- 50-day average slope (20 days)
- +1.7%
- 200-day average slope (20 days)
- +1.2%
- Distance from 50-day average
- -2.2%
- Distance from 200-day average
- +7.2%
- RSI (14)
- 43.3
- Relative volume
- 1.04×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 23.8%
- Volatility vs own 5-year history
- 1th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.27
- Correlation with S&P 500
- 0.49
- Current drawdown from 1-year high
- -6.9%
- Maximum drawdown, 3 years
- -43.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Mar 12, 2021 | Nov 17, 2022 | -79.5% | 426 days | Not yet recovered |
| Dec 2, 2020 | Jan 8, 2021 | -10.7% | 25 days | 20 days (Feb 8, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $5.20B
- P/E (TTM)
- 31.8
- EPS, diluted (TTM)
- $0.57
- Revenue (TTM)
- $1.22B
- 52-week range
- $13.09 – $19.85
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $931.5M | $1.00B | $1.05B | $1.10B | $1.16B |
| Gross profit | $518.7M | $557.0M | $577.2M | $602.3M | $645.5M |
| Operating income | $256.7M | $248.3M | $276.7M | $297.6M | $392.8M |
| Net income | $116.9M | -$233.6M | $51.4M | $44.4M | $77.9M |
| EPS (diluted) | $0.41 | -$0.83 | $0.18 | $0.16 | $0.27 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $285.5M | $290.2M | $254.5M | $294.3M | $311.3M | $303.4M | $280.0M | $321.4M |
| Net income | $17.0M | $12.3M | -$13.3M | $8.0M | $48.4M | $34.8M | $26.6M | $53.6M |
| EPS (diluted) | $0.06 | $0.04 | -$0.05 | $0.03 | $0.17 | $0.12 | $0.09 | $0.19 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $281.5M | $278.0M | -$147.7M | $224.2M | $287.2M |
| Capital expenditure | -$102.2M | -$182.4M | -$215.0M | -$179.1M | -$138.0M |
| Free cash flow | $179.4M | $95.6M | -$362.7M | $45.1M | $149.2M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$1.4M | -$393,000 | -$4.1M | -$4.4M | -$6.6M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $356.7M
- Total assets
- $3.31B
- Total liabilities
- $2.64B
- Total debt
- $2.27B
- Net debt
- $1.91B
- Shareholders’ equity
- $665.6M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 12,272,393
- Days to cover
- 7.25
- Change vs previous report
- +2.6%
FINRA short interest, settlement date Sep 15, 2026.